Literature DB >> 33243756

EGFRvIII uses intrinsic and extrinsic mechanisms to reduce glioma adhesion and increase migration.

Afsheen Banisadr1, Mariam Eick2, Pranjali Beri2, Alison D Parisian1, Benjamin Yeoman2,3, Jesse K Placone2, Adam J Engler4,5, Frank Furnari4,6.   

Abstract

A lack of biological markers has limited our ability to identify the invasive cells responsible for glioblastoma multiforme (GBM). To become migratory and invasive, cells must downregulate matrix adhesions, which could be a physical marker of invasive potential. We engineered murine astrocytes with common GBM mutations, e.g. Ink4a (Ink) or PTEN deletion and expressing a constitutively active EGF receptor truncation (EGFRvIII), to elucidate their effect on adhesion. While loss of Ink or PTEN did not affect adhesion, counterparts expressing EGFRvIII were significantly less adhesive. EGFRvIII reduced focal adhesion size and number, and these cells - with more labile adhesions - displayed enhanced migration. Regulation appears to depend not on physical receptor association to integrins but, rather, on the activity of the receptor kinase, resulting in transcriptional integrin repression. Interestingly, EGFRvIII intrinsic signals can be propagated by cytokine crosstalk to cells expressing wild-type EGFR, resulting in reduced adhesion and enhanced migration. These data identify potential intrinsic and extrinsic mechanisms that gliomas use to invade surrounding parenchyma.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Adhesion; Cancer; Extracellular matrix; Invasion

Mesh:

Substances:

Year:  2020        PMID: 33243756      PMCID: PMC7774888          DOI: 10.1242/jcs.247189

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  49 in total

1.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

2.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

3.  Loss of P16INK4 expression is frequent in high grade gliomas.

Authors:  R Nishikawa; F B Furnari; H Lin; W Arap; M S Berger; W K Cavenee; H J Su Huang
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

Review 4.  Oncogenic EGFR signaling networks in glioma.

Authors:  Paul H Huang; Alexander M Xu; Forest M White
Journal:  Sci Signal       Date:  2009-09-08       Impact factor: 8.192

Review 5.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

6.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

7.  αV-class integrins exert dual roles on α5β1 integrins to strengthen adhesion to fibronectin.

Authors:  Mitasha Bharadwaj; Nico Strohmeyer; Georgina P Colo; Jonne Helenius; Niko Beerenwinkel; Herbert B Schiller; Reinhard Fässler; Daniel J Müller
Journal:  Nat Commun       Date:  2017-01-27       Impact factor: 14.919

8.  Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.

Authors:  Anne Dirkse; Anna Golebiewska; Thomas Buder; Petr V Nazarov; Arnaud Muller; Suresh Poovathingal; Nicolaas H C Brons; Sonia Leite; Nicolas Sauvageot; Dzjemma Sarkisjan; Mathieu Seyfrid; Sabrina Fritah; Daniel Stieber; Alessandro Michelucci; Frank Hertel; Christel Herold-Mende; Francisco Azuaje; Alexander Skupin; Rolf Bjerkvig; Andreas Deutsch; Anja Voss-Böhme; Simone P Niclou
Journal:  Nat Commun       Date:  2019-04-16       Impact factor: 14.919

9.  Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine.

Authors:  K Bijian; C Lougheed; J Su; B Xu; H Yu; J H Wu; K Riccio; M A Alaoui-Jamali
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

10.  Cation type specific cell remodeling regulates attachment strength.

Authors:  Alexander Fuhrmann; Julie Li; Shu Chien; Adam J Engler
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more
  1 in total

1.  Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.

Authors:  Lorenzo Monteleone; Barbara Marengo; Francesca Musumeci; Giancarlo Grossi; Anna Carbone; Giulia E Valenti; Cinzia Domenicotti; Silvia Schenone
Journal:  Pharmaceutics       Date:  2022-07-01       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.